- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-637/15 P: Order of the Court (Eighth Chamber) of 25 October 2016 — VSM Geneesmiddelen BV v European Commission (Appeal — Article 181 of the Rules of Procedure of the Court of Justice — Public health — Consumer protection — Regulation (EC) No 1924/2006 — Health claims on foods — Article 13(3) — Community list of permitted health claims on foods — Botanical substances — Claims on hold — Action for failure to act and for annulment — Definition of position by the European Commission — Challengeable act)
ECLI:EU:UNKNOWN:62015CB0637
62015CB0637
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
27.2.2017
Official Journal of the European Union
C 63/7
(Case C-637/15 P) (<a id="ntc1-C_2017063EN.01000702-E0001" href="#ntr1-C_2017063EN.01000702-E0001"> (<span class="super note-tag">1</span>)</a>)
((Appeal - Article 181 of the Rules of Procedure of the Court of Justice - Public health - Consumer protection - Regulation (EC) No 1924/2006 - Health claims on foods - Article 13(3) - Community list of permitted health claims on foods - Botanical substances - Claims on hold - Action for failure to act and for annulment - Definition of position by the European Commission - Challengeable act))
(2017/C 063/11)
Language of the case: English
Parties
Appellant: VSM Geneesmiddelen BV (represented by: U. Grundmann, Rechtsanwalt)
Other party to the proceedings: European Commission (represented by: M. Wilderspin and S.Grünheid, Agents)
Operative part of the order
1.The appeal is dismissed.
2.There is no need to rule on the application for leave to intervene lodged by the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE).
3.VSM Geneesmiddelen BV shall pay the costs relating to the appeal proceedings.
4.VSM Geneesmiddelen BV and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) shall bear their own costs relating to EUCOPE’s application for leave to intervene.
(<a id="ntr1-C_2017063EN.01000702-E0001" href="#ntc1-C_2017063EN.01000702-E0001">(<span class="super">1</span>)</a> <a href="./../../../../legal-content/EN/AUTO/?uri=OJ:C:2016:048:TOC">OJ C 48, 8.2.2016</a>.)